tryptophan has been researched along with Hepatitis C, Chronic in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bugajska, J; Inglot, M; Janocha-Litwin, J; Malyszczak, K; Marciniak, D; Pawlak, D; Pawlowski, T; Zalewska, M | 1 |
| Inglot, M; Laskus, T; Malyszczak, K; Pawlak, D; Pawlowski, T; Radkowski, M; Zalewska, M | 1 |
| Gruenhage, F; Hahn, D; Kaiser, R; Lammert, F; Meyer, MR; Stokes, CS | 1 |
| Baranyi, A; Breitenecker, RJ; Kapfhammer, HP; Meinitzer, A; Putz-Bankuti, C; Rothenhäusler, HB; Stauber, R; Stepan, A | 1 |
| Igarashi, K; Katsumi, T; Nishise, Y; Okumoto, K; Saito, K; Saito, T; Sato, C; Shao, L; Soga, T; Sugimoto, M; Tomita, K; Tomita, M; Ueno, Y; Watanabe, H | 1 |
| Fujigaki, H; Imamura, Y; Ishibashi, T; Kim, HC; Kubo, H; Mamiya, T; Mitani, S; Murakami, Y; Nabeshima, T; Nishikawa, M; Ohta, Y; Saito, K; Takahashi, Y; Takakura, Y; Tashiro, T; Tomita, E; Watcharanurak, K; Yamamoto, Y | 1 |
| Canva, V; Costisella, O; Duhamel, A; Imbenotte, M; Lhermitte, M; Vignau, J | 1 |
| Bernardinello, E; Bertazzo, A; Cavalletto, L; Chemello, L; Comai, S; Costa, CV; Ragazzi, E | 1 |
| Koek, GH; Maes, M; Robaeys, G; Scharpé, S; Verkerk, R; Wichers, MC | 1 |
| Aldinucci, A; Biagiotti, T; Carpendo, R; Cozzi, A; Giannini, C; Laffi, G; Monti, M; Moroni, F; Rosselli, M; Zignego, AL | 1 |
| Aldinucci, A; Biagioli, T; Carpenedo, R; Cozzi, A; Giannini, C; Laffi, G; Moroni, F; Rosselli, M; Zignego, AL | 1 |
| Almerighi, C; Artini, M; Biondi, M; Bonaccorso, S; Maes, M; Marino, V; Meltzer, H; Pasquini, M; Puzella, A; Verkerk, R | 1 |
3 trial(s) available for tryptophan and Hepatitis C, Chronic
| Article | Year |
|---|---|
Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis.
Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Betaine; Carnitine; Chromatography, Liquid; Drug Therapy, Combination; Female; Glycine; Hepatitis C, Chronic; Humans; Interferons; Male; Metabolomics; Middle Aged; Polyethylene Glycols; Principal Component Analysis; Ribavirin; Tandem Mass Spectrometry; Treatment Outcome; Tryptophan; Viral Load | 2013 |
IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Topics: Adult; Depression; Dioxygenases; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Kynurenic Acid; Kynurenine; Male; Middle Aged; Psychiatric Status Rating Scales; Tryptophan | 2005 |
Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hepatitis C, Chronic; Humans; Immunotherapy; Interferon alpha-2; Interferon-alpha; Kynurenine; Male; Middle Aged; Personality Inventory; Receptors, Serotonin; Recombinant Proteins; Serotonin; Tryptophan | 2002 |
9 other study(ies) available for tryptophan and Hepatitis C, Chronic
| Article | Year |
|---|---|
The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
Topics: Adult; Antiviral Agents; Cross-Sectional Studies; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Immunologic Factors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Kynurenic Acid; Kynurenine; Longitudinal Studies; Male; Middle Aged; ortho-Aminobenzoates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tryptophan | 2021 |
Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-α 2a treatment.
Topics: Adult; Antiviral Agents; Depression; Depressive Disorder; Female; Hepatitis C; Hepatitis C, Chronic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Kynurenic Acid; Kynurenine; Male; Middle Aged; ortho-Aminobenzoates; Polyethylene Glycols; Recombinant Proteins; Tryptophan | 2018 |
Antidepressant effects of direct-acting antivirals against hepatitis C virus-Results from a pilot study.
Topics: Actigraphy; Adult; Aged; Antiviral Agents; Depression; Exercise; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Pilot Projects; Ribavirin; Treatment Outcome; Tryptophan; Viral Load; Young Adult | 2018 |
A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection.
Topics: Adult; Analysis of Variance; Depressive Disorder; Female; Hepatitis C, Chronic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Interview, Psychological; Kynurenic Acid; Kynurenine; Male; Models, Theoretical; Neuropsychological Tests; Personal Satisfaction; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Risk Factors; Sex Factors; Social Support; Surveys and Questionnaires; Thyroid Function Tests; Tryptophan | 2013 |
Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.
Topics: Animals; Behavior, Animal; Depression; Enzyme Induction; Female; Frontal Lobe; Hepatitis C, Chronic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Interferon-gamma; Kynurenine; Male; Metabolome; Mice, Inbred C57BL; Middle Aged; Serotonin; Swimming; Tryptophan | 2016 |
[Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Topics: Adult; Antiviral Agents; Anxiety Disorders; Blood Platelets; Depressive Disorder; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Kynurenine; Male; Middle Aged; Personality Inventory; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Serotonin; Tryptophan | 2009 |
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Case-Control Studies; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon alpha-2; Interferon-alpha; Italy; Kynurenine; Male; Middle Aged; Polyethylene Glycols; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Serotonin; Time Factors; Treatment Outcome; Tryptophan | 2011 |
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.
Topics: Adult; Anxiety; Depression; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Macrophages; Male; Middle Aged; Tryptophan | 2006 |
HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon alpha-2; Interferon-alpha; Kynurenine; Macrophages; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tryptophan | 2007 |